|
|
|
|
 |
|
|
| |
Research > MDMA-Assisted Psychotherapy
|
MDMA/PTSD Canada Study
MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD)
Principal Investigator: Ingrid Pacey, MD and Andrew Feldmar, PhD
Location: Vancouver, BC (Canada)
This study has full approval from an Institutional Review Board (IRB) and from Health Canada. Data will also be submitted to the U.S. FDA. Psychiatrist Ingrid Pacey, M.D., a distinguished Holotropic Breathwork facilitator and psychologist Andrew Feldmar, Ph.D. will be the co-therapists leading the study. We are currently working to obtain an import permit to import the MDMA into Canada from a pharmacologist in Switzerland. The study will begin enrollment after the import permit is obtained and an amended protocol is approved by the IRB.
Canadian
MDMA/PTSD pilot study protocol
The study will cost $290,000; $279,000 of which remains to be raised.
View the timeline for this study.
|
|
|
|
|
|
